135 related articles for article (PubMed ID: 38160436)
21. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
22. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Walsh JA; Pei S; Penmetsa GK; Sauer BC; Patil V; Walker JH; Clewell J; Douglas KM; Clegg DO; Cannon GW; Halwani A
J Manag Care Spec Pharm; 2019 Nov; 25(11):1218-1228. PubMed ID: 31663467
[TBL] [Abstract][Full Text] [Related]
23. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
24. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
Boytsov NN; Bhattacharya R; Saverno K; Dixon L; Abbott PL; Zhang X; Gaich CL; Nair R
J Manag Care Spec Pharm; 2019 Aug; 25(8):879-887. PubMed ID: 31347977
[TBL] [Abstract][Full Text] [Related]
25. Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data.
Lee H; Sparks JA; Lee SB; Yoshida K; Landon JE; Kim SC
Pharmacoepidemiol Drug Saf; 2023 May; 32(5):586-591. PubMed ID: 36728737
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population.
Crane MM; Juneja M; Allen J; Kurrasch RH; Chu ME; Quattrocchi E; Manson SC; Chang DJ
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1646-55. PubMed ID: 26097059
[TBL] [Abstract][Full Text] [Related]
27. Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan.
Katada H; Yukawa N; Urushihara H; Tanaka S; Mimori T; Kawakami K
Clin Rheumatol; 2015 May; 34(5):949-56. PubMed ID: 24420724
[TBL] [Abstract][Full Text] [Related]
28. Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.
Curtis JR; Chen SY; Werther W; John A; Johnson DA
Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1150-8. PubMed ID: 22020901
[TBL] [Abstract][Full Text] [Related]
29. A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: case-control and cohort diagnostic accuracy studies. Results from the RECord linkage On Rheumatic Diseases study of the Italian Society for Rheumatology.
Carrara G; Scirè CA; Zambon A; Cimmino MA; Cerra C; Caprioli M; Cagnotto G; Nicotra F; Arfè A; Migliazza S; Corrao G; Minisola G; Montecucco C
BMJ Open; 2015 Jan; 5(1):e006029. PubMed ID: 25631308
[TBL] [Abstract][Full Text] [Related]
30. Disease-modifying antirheumatic drug initiation among patients newly diagnosed with rheumatoid arthritis.
Bonafede M; Johnson BH; Shah N; Harrison DJ; Tang D; Stolshek BS
Am J Manag Care; 2018 Jul; 24(8 Spec No.):SP279-SP285. PubMed ID: 30020740
[TBL] [Abstract][Full Text] [Related]
31. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
Kamata Y; Minota S
Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Rheumatoid Arthritis and Drug Dispensing Patterns Among Medicaid and Medicaid-Medicare Dually Eligible Beneficiaries in Puerto Rico.
Hernández-Muñoz JJ; Wei W; Sierra-Zorita R
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):199-206. PubMed ID: 32475025
[TBL] [Abstract][Full Text] [Related]
33. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G; Barner JC; Rascati K; Richards K
Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
[TBL] [Abstract][Full Text] [Related]
34. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.
Furuya T; Oh K; Ikari K; Inoue E; Tanaka E; Yamanaka H; Harigai M
Clin Rheumatol; 2022 Feb; 41(2):405-410. PubMed ID: 34586516
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.
Hunter TM; Boytsov NN; Zhang X; Schroeder K; Michaud K; Araujo AB
Rheumatol Int; 2017 Sep; 37(9):1551-1557. PubMed ID: 28455559
[TBL] [Abstract][Full Text] [Related]
37. Databases of patients with early rheumatoid arthritis in the USA.
Sokka T; Willoughby J; Yazici Y; Pincus T
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S146-53. PubMed ID: 14969067
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Kim G; Barner JC; Rascati K; Richards K
J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data.
Gharaibeh M; Bonafede M; McMorrow D; Hernandez EJM; Stolshek BS
J Manag Care Spec Pharm; 2020 Aug; 26(8):1039-1049. PubMed ID: 32715967
[TBL] [Abstract][Full Text] [Related]
40. Validation of a claims-based algorithm to identify cases of ulcerative colitis in Japan.
Ogino H; Morikubo H; Fukaura K; Okui T; Gardiner S; Sugiyama N; Yoshii N; Kawaguchi T; Chen H; Nonnenmacher E; Setoguchi S; Nakashima N; Kobayashi T
J Gastroenterol Hepatol; 2022 Mar; 37(3):499-506. PubMed ID: 34738649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
